NCT00775086View on ClinicalTrials.gov

Bioequivalence Study of Patches With Different Equilibration Profiles

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

August 31, 2004

Conditions
Female Contraception
Interventions
DRUG

norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00775086 - Bioequivalence Study of Patches With Different Equilibration Profiles | Biotech Hunter | Biotech Hunter